Business
Novo Nordisk Shares Plunge 20% After Disappointing CagriSema Trial Results
Novo Nordisk experienced its sharpest one-day decline in history on Friday as shares of the Danish pharmaceutical giant plummeted 20% following underwhelming trial results for its new obesity drug, CagriSema. The drop wiped out €90 billion in market valuation, significantly impacting the year-to-date performance of Europe’s largest company, which is now down 16% in 2024.
CagriSema Misses Expectations
The phase 3 trial for CagriSema revealed a weight loss of 22.7% over 68 weeks, below the projected 25% benchmark. The figure fell further to 20.4% among patients who did not strictly adhere to the treatment regimen. The results raised concerns about Novo Nordisk’s competitiveness in the rapidly growing obesity and diabetes drug market.
Eli Lilly, Novo Nordisk’s primary U.S.-based rival, reported a 24% weight loss in September with its latest drug, retatrutide. Eli Lilly’s stock surged 10% before closing 1.35% higher on Friday and has gained 32% this year, a stark contrast to Novo Nordisk’s performance.
Adding to the disappointment, only 57% of CagriSema trial participants reached the highest dose, compared to 83% for cagrilintide and 70% for semaglutide in previous studies. Concerns about the drug’s side effects and market positioning have tempered investor expectations.
“Based on insights from the REDEFINE 1 trial, we will explore additional weight loss potential for CagriSema,” said Martin Holst Lange, Novo Nordisk’s executive vice president for Development. Results from a second phase 3 trial, REDEFINE 2, are expected in the first half of 2025.
Heightened Competition in the Weight-Loss Market
The global market for weight-loss and diabetes drugs, including GLP-1 treatments, is projected to grow to between $150 billion and $200 billion by 2030. Novo Nordisk’s weight-loss drug Wegovy and diabetes treatment Ozempic accounted for 61% of the company’s sales in the first nine months of 2024.
Eli Lilly has emerged as a formidable competitor with its weight-loss drugs Zepbound and Mounjaro. The U.S.-based company, valued at $691 billion (€662 billion), has positioned itself as a market leader, with analysts expecting the two firms to evenly split the weight-loss market by the end of 2024.
Future Challenges for Novo Nordisk
Novo Nordisk faces mounting pressure to expedite next-generation drug development as the patent for Wegovy is set to expire in the early 2030s. The disappointing results for CagriSema have raised doubts about the company’s ability to sustain its dominance in the sector.
The U.S. remains Novo Nordisk’s largest market, accounting for 35% of its diabetes drug sales as of August 2024. While the company’s valuation peaked in June, Friday’s market reaction underscores the challenges it faces in retaining its competitive edge in a rapidly evolving industry.
Business
Iran Conflict Sparks Global Fertiliser Crunch, Raising Fears for Food Security
The war involving Iran and the continued blockade of the Strait of Hormuz are beginning to ripple through global agriculture, with rising fertiliser costs threatening food production and pushing farmers under increasing financial strain.
A new World Bank report warns that soaring energy prices and disrupted trade routes have created a severe fertiliser squeeze, driving affordability for farmers to its lowest level in four years. The crisis is being fuelled largely by a sharp rise in natural gas prices, a key ingredient in the production of nitrogen-based fertilisers.
Because fertiliser production is closely tied to energy markets, any spike in gas prices quickly translates into higher costs for farmers. That dynamic is now raising concerns about the impact on future harvests, particularly in regions already facing economic and food security challenges.
European agriculture ministers are reportedly discussing emergency measures to shield farmers from escalating costs and to protect grain production for next year. While Europe is not currently facing an immediate supply shortage, industry groups say the pressure on farm finances is intensifying.
A spokesperson for Fertilisers Europe said the continent remains relatively well supplied, thanks to strong domestic production and high import levels in recent months. Europe typically meets around 70% of its fertiliser demand through its own output.
However, the organisation warned that farmers are operating on increasingly narrow margins. It called for targeted support from European Union institutions while also ensuring that assistance does not undermine the competitiveness of the region’s fertiliser industry.
The situation is more severe outside Europe. According to the UN Food and Agriculture Organization, shipping disruptions through the Strait of Hormuz have caused significant fertiliser shortages across Asia, the Middle East and parts of Africa.
Countries including India, Bangladesh, Sri Lanka, Egypt, Sudan and several nations in sub-Saharan Africa are facing rising costs, reduced availability and growing risks to food security.
Analysts warn that if farmers cut fertiliser use to save money, crop yields could fall sharply in the next planting season. Research from the International Food Policy Research Institute suggests that reduced application rates would likely lower global grain production and tighten food supplies.
The FAO’s Food Price Index has already begun to rise, reflecting mounting concerns over input costs and supply disruptions. Higher transport expenses and logistical challenges linked to the conflict are expected to place additional upward pressure on food prices in the months ahead.
For many developing economies already struggling with inflation, the impact could be especially severe. Policymakers may face difficult choices as they seek to balance economic stability with food affordability.
Experts say the crisis underscores the importance of securing not only food supplies, but also the essential inputs that make food production possible. Without a stabilisation of energy markets and a restoration of normal shipping routes, the effects of the Iran conflict could linger far beyond the battlefield.
Business
Oil Markets Jolt as UAE Exits OPEC Amid Strait of Hormuz Crisis
Business
UAE’s OPEC Exit Marks New Chapter for Gulf Energy Strategy
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
